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THE EFFECT OF RECALL PERIOD ON CANCER PATIENTS’ RATINGS OF
THE SEVERITY OF MULTIPLE SYMPTOMS
Shi Q1, Trask PC2, Wang S1, Mendoza T1, Cleeland C1
1University of Texas M. D. Anderson Cancer Center, Houston, TX, USA, 2Pﬁ zer, New London, 
CT, USA
In response to the US Food and Drug Administration’s concern on choice of suitable 
recall period for patient-reported outcomes (PRO), we examined the effects of recall
on symptom severity ratings by comparing ratings made using 24-hour and 7-day 
recall periods of the MD Anderson Symptom Inventory (MDASI). METHODS: Forty-
two patients at their 3rd to 8th week of chemoradiation in the Radiation Treatment 
Center at M.D. Anderson Cancer Center were asked to rate their symptoms using the
MDASI on two separate occasions, one week apart. At the initial visit, patients were
randomly assigned to rate their symptoms using either a 24-hour recall or a 7-day 
recall. On their next visit, patients were asked to rate their symptoms using the recall
period not used at their ﬁ rst visit. RESULTS: Correlation coefﬁ cients of global
symptom severity between 24-hour and 7-day recall periods were 0.89. Examining 
individual items, all correlation coefﬁ cients were over 0.7 except for distress (r  0.67).
The percentages of moderate to severe symptoms (5 or greater) were consistent in the 
24-hour and 7-day recall periods, with no signiﬁ cant difference in the prevalence of 
moderate to severe symptoms being found between the two recall periods. Cronbach 
á coefﬁ cients in both 24-hour and 7-day recalls were all over 0.8. Symptoms from 
both recall periods were more severe for patients with poorer performance status. 
Among 20 patients who underwent cognitive debrieﬁ ng, 70% thought the 7-day recall 
was “more appropriate” for answering the MDASI, but 85% did not think that recall 
period would inﬂ uence their answers. CONCLUSIONS: This study demonstrated that
a 7-day recall version of the MDASI has psychometric properties consistent with the 
24-hour recall version, which may allow its use in future clinical trials. In addition, 
this study may help ease the choice of recall period when symptoms are outcome
measures.
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RELATIONSHIP BETWEEN QUALITY OF LIFE AND HEALTH-RELATED 
MEASURES INCLUDING SYMPTOMS, BIOCHEMICAL MARKERS AND
TUMOR BURDEN
Vinik EJ, Vinik AI, Silva MP
Eastern Virginia Medical School, Norfolk, VA, USA
OBJECTIVES: Examine the relationship of quality of life measures in neuroendocrine 
tumor patients using the Norfolk QOL-NET by correlating the total questionnaire 
score with each of the Norfolk QOL-NET domains, with tumor burden, biochemical 
status and the Norfolk Carcinoid Symptom Score tool. METHODS: During their
visits to the Neuroendocrine Unit at Eastern Virginia Medical School, 29 adult 
patients diagnosed with neuroendocrine tumor(s) signed the consent form and com-
pleted the Norfolk QOL-NET. Data related to current tumor burden, biochemical
status and the validated Carcinoid Symptom Score was obtained from their ﬁ les 
matching the date they completed the questionnaires. RESULTS: The Norfolk QOL-
NET total score correlated positively with all of its domains – physical functioning 
(r  0.96, p  0.0001), depression(r  0.73, p  0.001), gastrointestinal (r  0.78,
p  0.001), ﬂ ushing (r  0.62, p  0.0003), respiratory (r  0.65, p  0.0002), positive 
attitude (r  0.52, p  0.004), and cardiovascular (r  0.46, p  0.012); with the 
Norfolk Carcinoid Symptom Score (r  0.6, p  .0001); with tumor burden (r  0.52,
p  0.004), and serotonin (r  0.62, p  0.013). Serotonin was the only biochemical 
marker that correlated positively with a poor quality of life in patients with neuroen-
docrine tumors. CONCLUSIONS: We demonstrated a strong correlation between 
Norfolk QOL-NET and symptoms, biochemical markers and tumor burden. Norfolk 
QOL-NET seems sensitive to symptom change, physical functioning, respiratory and 
cardiovascular disease progression or remission. Norfolk QOL-NET should be an
important tool for measuring patients’ perception of the burden of their disease, relat-
ing to the tumor burden and the biochemical abnormality as well as the impact of 
treatment modalities. The Norfolk quality of life tool may also be a useful guide in 
deciding changes in therapy to alter apparent health status as well as an endpoint in
clinical studies.
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TEST-RETEST RELIABILITY OF THE EQ-5D VISUAL ANALOG SCALE 
ACROSS POPULATIONS AND CONDITIONS
Wilke CT1, Pickard AS2
1University of Illinois at Chicago, Chicago, IL, USA, 2College of Pharmacy, University of Illinois
at Chicago, Chicago, IL, USA
OBJECTIVES: As electronic versions of HRQL measures such as the EQ-5D become 
available, it is important to understand the reliability of different modes of technology. 
The aim of this study was to summarize the evidence of test-retest reliability for the
EQ-5D visual analog scale (VAS), a scale ranging from 0 (worst imaginable health) to 
100 (best imaginable health). METHODS: A structured literature search was con-
ducted in MEDLINE using keywords relevant to EQ-5D, visual analog scales, and
test-retest reliability. Original research studies that reported information on the test-
retest reliability of the EQ-5D VAS were included. Demographic characteristics, inter-
val between observations, and intraclass correlation coefﬁ cients (ICCs) were abstracted. 
RESULTS: Of the 25 studies that examined test-retest reliability of EQ-5D, 14 
reported evidence of test-retest reliability for EQ-5D VAS. Most of the papers were
studies that assessed the validity of EQ-5D for certain countries or languages (n 
5/14, 36%) or for use in patient groups / certain medical conditions (n  7/14, 50%). 
The most common interval between observations was 2 weeks (n  4/14, 29%), with 
analyses conducted on a subgroup of self-reported stable patients, based on self-report,
in 4 studies. TRT ICCs ranged from ICC  0.38 for Alzheimer’s patients to ICC 
0.90 (95% CI: 0.88–0.92) for a methodological study conducted in Spain, with a 
median ICC  0.8 across the 14 studies. Almost 80% of studies (11/14) reported ICCs 
above 0.7, a reliability threshold considered acceptable at the group level. CONCLU-
SIONS: EQ-5D VAS demonstrated acceptable TRT reliability in most studies of popu-
lations and medical conditions except in Alzheimer’s disease, where proxies but not 
patients provided reproducible assessments.
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PSYCHOMETRIC ASSESSMENT OF AN INSTRUMENT TO MEASURE
PATIENT SATISFACTION WITH MEDICATION THERAPY MANAGEMENT
SERVICES
Bodhani A1, West D2, Li C1, Ounpraseuth S1, Pace A1
1University of Arkansas for Medical Sciences, Little Rock, AR, USA, 2University of Mississippi
School of Pharmacy, University, MS, USA
OBJECTIVES: To adapt a pharmaceutical care satisfaction instrument and pilot 
test it to measure patient satisfaction with Medication Therapy Management (MTM) 
services. METHODS: A questionnaire was mailed to Medicare Part D beneﬁ ciaries 
who received face-to-face MTM services in a retail pharmacy in a southern state. The
questionnaire consisted 23 questions addressing patients’ perceptions, experience, and
satisfaction related to MTM services. Information regarding patients’ satisfaction was
gathered using an instrument developed by Gourley et al. (2001) with a few modiﬁ ca-
tions to make it applicable to MTM service encounter. We assessed the content validity
and pre-tested the questionnaire to determine the time needed to complete and to
ensure item clarity. Factor analysis using the principal component method with
varimax rotation and reliability analysis using Cronbach’s alpha was conducted. 
RESULTS: Of the 403 successfully mailed surveys; we received 122 useable surveys 
yielding a response rate of 30.27%. Sample comprised 55% females, 68% whites. 
Over 80% of the study participants took 5–16 unique medications daily. Factor analy-
sis using a 0.55 cut-off for factor loading yielded four factors that accounted for 
64.4% of the variance. Reliability assessment resulted in Cronbach’s alpha value of 
0.941 for the entire scale, 0.904 for factor 1 (Managing Medication Therapy), 0.917
for factor 2 (Patient Education), 0.910 for factor 3 (Overall Satisfaction), and 0.841 
for factor 4 (Pharmacist-Patient Relationship). The overall mean score was found to 
be 4.5/5 indicating that the participants were satisﬁ ed with the MTM services they 
received. CONCLUSIONS: The adapted questionnaire consisted of four subscales
similar to subscales found in other pharmacy satisfaction surveys. The instrument 
appears to be useful in measuring patient satisfaction with MTM services received in 
a pharmacy. Low sample size, extrapolation of results to other states and settings, and
recall bias are the notable limitations associated with this study.
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DETERMINING THE MINIMALLY IMPORTANT DIFFERENCES OF FOUR
PREFERENCE-BASED HEALTH INDICES: A SIMULATION APPROACH
Luo N1, Johnson JA2, Coons SJ3
1National University of Singapore, Singapore, Singapore, 2University of Alberta, Edmonton, 
AB, Canada, 3University of Arizona, Tucson, AZ, USA
OBJECTIVES: To estimate the minimally important differences (MIDs) for the EQ-
5D, HUI2, HUI3, and SF-6D health index scores using health-state transitions 
described by each instrument’s health classiﬁ cation systems as anchors. METHODS:
We assume that the smallest differences in health states deﬁ ned by each instrument’s 
multi-attribute health classiﬁ cation (MAHC) systems are associated with important 
differences in health preferences. Based on this assumption, the MID was deﬁ ned as 
the difference in index score between two health states deﬁ ned by each MAHC system 
differing in only one health dimension or attribute and by only one functional level.
Thus, for each instrument, we enumerated all the theoretically possible pairs of mini-
mally different health states and calculated the differences in index scores for those 
pairs of health states. RESULTS: Based on our deﬁ nitions, the total number of pairs 
of minimally different health states is 405 for the EQ-5D, 127,600 for the HUI2, 
6,382,800 for the HUI3, and 86,700 for the SF-6D. The mean (standard deviation) 
MID estimate was 0.040 (0.026) for the EQ-5D (US algorithm), 0.082 (0.032) for the
EQ-5D (UK algorithm), 0.045 (0.039) for the HUI2, 0.032 (0.027) for the HUI3, and
0.027 (0.028) for the SF-6D. The effect sizes corresponding to these MID estimates 
range from 0.19 to 0.28. In general, these MID estimates are quite comparable to 
those estimated using other anchor-based methods. CONCLUSIONS: This new 
approach to estimating the MIDs of four commonly used preference-based HRQoL 
index scores provides new and useful information for identifying and interpreting 
meaningful change (or differences) in scores.
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MEASURING POPULATION HEALTH STATUS USING EQ-5D: 
RESULTS FROM THE HEALTH SURVEY FOR ENGLAND 1996–2006
Zarate V1, Kind P2
1University of York, York, North Yorkshire, UK, 2University of York, York, UK
OBJECTIVES: The development of national health policies requires a clear under-
standing about how objective and subjective measures of health status vary over time.
This task is only possible when generic self-reported instruments are considered part 
of population surveys alongside traditional health indicators. This study examines 
variations in self-reported health status in England as measured by the EuroQol EQ-5D 
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questionnaire. METHODS: Data from the Health Survey for England (HSE) of 1996
(n  16,443) and 2006 (n  14,142) were selected in order to assess variation in popula-
tion health status over a 10 year period. Both surveys covered population aged 16 years
and over living in private households. The sample is regularly drawn using a multistage 
stratiﬁ ed random procedure that uses postcode sectors as the primary sample unit. 
Given that only the EQ-5D descriptive system is included to describe self-reported 
health in the HSE, a predicted EQ-5DVAS was estimated for each respondent based
on a regression model developed from data of the 1993 York Measurement and
Valuation of Health Project. RESULTS: Despite being older (2.59 years on average, 
p-value 0.001) and having a slightly higher proportions of women (0.8 percent, p-
value 0.156), the 2006 HSE reﬂ ects that English population has signiﬁ catively (p-value
0.001) reduced its prevalence of self-reported health problems in the last 10 years in 
three out of ﬁ ve EQ-5D dimensions: usual activities, pain/discomfort and anxiety/
depression. Mobility and self-care dimensions, although higher in prevalence, did not
reach statistical signiﬁ cance at 5% level when both years were compared. Health
improvements over time were also reﬂ ected in the utility-weighted EQ-5DINDEX and
predicted EQ-5DVAS (p-value 0.001), having the 16–44 age-group and women the
highest health gains. CONCLUSIONS: EQ-5D is a useful tool for monitoring popula-
tion health. Our ﬁ ndings will assist local policymakers and public health authorities
by improving their knowledge about trends in self-perceived health.
PMC62
ASSESSING THE QUALITY OF CONJOINT ANALYSIS APPLICATIONS 
IN HEALTH: A PILOT EVALUATION OF THE ISPOR CHECKLIST FOR
GOOD RESEARCH PRACTICE IN CONJOINT ANALYSIS
Marshall DA1, Hauber AB2, Bridges JF3, Cameron R4, Weaver L2, Dionne J4, Johnson FR2
1University of Calgary, Calgary, AB, Canada, 2RTI Health Solutions, Research Triangle Park, NC, 
USA, 3Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA, 
4McMaster University, Hamilton, ON, Canada
OBJECTIVES: Increasingly, conjoint analysis , a stated-preference method, is applied
in health outcomes research. Variation in method type and quality make it difﬁ cult to
assess substantive ﬁ ndings. The ISPOR Conjoint Analysis Database Project was estab-
lished to identify and evaluate empirical conjoint analysis applications in the literature 
using the 10-point ISPOR Checklist for Good Research Practice in Conjoint Analysis
(the Checklist). METHODS: Multiple electronic databases published between 1980 
and 2008 were searched to identify conjoint-analysis applications in human health 
studies. Only English-language publications were incorporated. Included studies were
subject to detailed data extraction including descriptive information, methodological
details on survey type, experimental design, survey format, attributes and levels,
sample size, number of conjoint tasks per respondent, and analysis methods. Review 
articles and methods studies were excluded. The detailed extraction form was piloted
to identify key elements to be included in the database using a standardized taxonomy
and to test the Checklist as an evaluative framework for the methodological assessment 
of these studies. RESULTS: The search identiﬁ ed 2,365 citations – 264 met inclusion 
criteria. The number of applied studies increased substantially over time (1980–85 
5 and 2007  42) in a broad range of applications, cancer being the most frequent.
Based on the pilot results, discrete-choice experiments using fractional factorial
designs were most common. Attribute number ranged from 3–6, choice tasks per
respondent ranged from 8–16 and sample size ranged from 30–335. Studies generally
reported less information than required by the 10-point Checklist, especially regarding 
methods used to generate experimental design and reporting design properties. 
CONCLUSIONS: Conjoint analysis in health has expanded to include a broad range 
of applications and methodological approaches. The Checklist provides a framework 
to assess their quality. The conjoint analysis Database project will complete the assess-
ment of the quality and variability of these studies based on the pilot ﬁ ndings.
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THE TRANSLATION AND LINGUISTIC VALIDATION OF THE
NEUROPATHY TOTAL SYMPTOM SCORE-6 SELF-ASSESSED VERSION
(NTSS-6 SA)
Furtado T, Gordon-Stables R, Wild D
Oxford Outcomes Ltd, Oxford, UK
The NTSS-6 SA has been translated into many different languages. It is designed to
assess the severity of peripheral neuropathy symptoms. The objective of this study was
to produce translations that are conceptually equivalent to the original and to other 
language versions, ensuring the relevance of the translations within the target cultures. 
A standard methodology was employed: 2 forward translations, a reconciliation of 
the forward translations, 2 back translations, back translation review; or an in-country 
review; linguistic validation interviews with 5 patients with diabetic peripheral neu-
ropathy in each country, and 2 proofreadings. Numerous cultural and linguistic issues 
became apparent throughout the translation process, including the following: – Many
different pain types are described (e.g. stabbing, shooting, electric-shock like, boring,
aching) which were particularly difﬁ cult as this vocabulary was unavailable in some 
languages. A decision was made to assign the pain types into two groups; ﬁ rstly dull, 
aching pains, and secondly sharper, stabbing pains. These could then be more easily
conveyed and translated. – For many countries, there was no direct translation for
‘pins and needles’. If the country had no idiomatic description of this, ‘feeling as if 
ants crawl on the skin’ was used. – Some items ask about ‘feet’; many of the countries
involved have no speciﬁ c word for ‘feet’, so ‘from ankle to toes’ was translated. – Some
languages were unable to convey ‘asleep feeling’ in a limb; this wording was therefore
converted to ‘numbness’. The NTSS-6 SA has been translated and linguistically vali-
dated using a rigorous translation process. A number of cultural and linguistic issues 
became apparent and were resolved. The measure is now appropriate for use in mul-
tinational trials.
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DEVELOPMENT OF A CHECKLIST TO ASSESS THE QUALITY OF
TRANSLATIONS OF PATIENT-REPORTED OUTCOMES (PRO)
INSTRUMENTS
Conway K1, Acquadro C2
1MAPI Research Trust, Lyon, France, 2Hopital Saint-Louis, Paris, France
OBJECTIVES: Previous research for existing classiﬁ cation systems for translations of 
PRO instruments have shown that existing classiﬁ cations 1) do not give formal evi-
dence of the added value of any one step of the translation process; 2) do not address
the importance of the number of translators or their qualiﬁ cation; and 3) do not give 
formal assurance of the intrinsic quality of the translations. Therefore there is a need 
to develop a comprehensive tool in form of a checklist to assess the quality of the 
translations of PRO instruments. This is the objective of our study. METHODS: We 
conducted 1) interviews with project leaders involved in the translation of PRO instru-
ments; 2) a review of the process used to translate more than 300 instruments in up 
to 130 languages since 1995; and 3) a literature search with the following key words: 
translation, quality, assessment, control and evaluation. RESULTS: Sixteen articles 
were retrieved. The review of these and the interviews conﬁ rmed that 3 key elements
should be assessed at each step of the linguistic validation process, i.e. the method 
used, the team involved and the quality of the end-product. The quality evaluation
should be based on the availability (or not) of evidence backing each step. Mandatory 
evidence required for each step should be provided. For instance, evidence of the 
conceptual deﬁ nition of the different items as deﬁ ned by the developer should be 
provided as well as evidence that translations are conducted within the target coun-
tries. In the pilot test step, evidence of background information and participation of 
subjects should be included. The checklist is currently under development and will be 
presented. CONCLUSIONS: The checklist will provide an increasing level of conﬁ -
dence about the validity of a translation for the context in which the PRO measure
and its translation will be used.
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A NOVEL COMPARISON OF QUALITATIVE DATA SOURCES: 
CONTENT ANALYSIS OF SEMI – STRUCTURED PATIENT
INTERVIEWS VERSUS WEBLOGS (BLOGS)
Acaster SL1, Wild D2
1Oxford Outcomes, Oxford, UK, 2Oxford Outcomes Ltd, Oxford, UK
OBJECTIVES: Blogs have become a fruitful source of qualitative data in recent years
and, as there is a relative lack of qualitative data in many areas of health research, 
this new data source could provide valuable insight in the early stages of research 
development. As such, the objective of this study was to assess the potential use of 
blogs in research development by comparing the data available in blogs with that 
gained from conducting semi-structured interviews with patients. METHODS: The 
subject of menopausal hot ﬂ ashes was used to demonstrate the comparison. Twenty 
semi – structured interviews were conducted with women reporting to suffer hot
ﬂ ashes. The interviews focussed on a description of the symptoms and their impact 
on HRQoL. The themes emerging from the content analysis of these interviews was
then compared to the themes found in twenty blog entries. Four researchers conducted
the analysis, two in each data source group. RESULTS: Both the semi – structured 
interview data and the blog data provided numerous descriptions of the symptoms of 
hot ﬂ ashes, with no discrepancies in thematic content. The interviews did however
allow an explicit discussion of the range in symptom severity and the relationship
between hot ﬂ ashes and night sweats, which could only be inferred in the blog analysis.
Similarly, the effect of hot ﬂ ashes on physical and social functioning, and psychological 
wellbeing, produced similar themes in both data sources. However, while the inter-
views permitted clariﬁ cation of the impact of symptoms on HRQoL, blog analysis 
often relied on inference. CONCLUSIONS: The broad themes elicited from both data
sources were comparable. However, the interactive nature of the interviews produced 
richer, more reliable data than that contained within the blogs. As such the role of 
blog analysis could be that of a cost effective adjunct to literature searches when 
developing research protocols.
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USE OF THE MINI INTERNATIONAL NEUROPSYCHIATRIC
INTERVIEW (M.I.N.I.) – VERSION 6 – IN AN INTERNATIONAL STUDY
Boudrot A1, D’uva F2, Sheehan D3, Lecrubier Y4, Even C4
1Mapi Research Institute, Lyon, France, 2Mapi Research Institute, LYON, France, 3University of 
South Florida, Tampa, FL, USA, 4Centre Hospitalier Sainte-Anne, Paris, France
The M.I.N.I. is a semi-structured interview designed to explore and diagnose psychiat-
ric disorders in research and clinical settings. Various versions of the US English instru-
ment exist (M.I.N.I. Kid, M.I.N.I. Plus, etc.). Since its development in 1990 some or
all versions of the original have been translated into more than 40 languages. OBJEC-
TIVES: Before using version 6 in 12 countries, it had to be translated according
to a rigorous methodology to meet 3 requirements: (1) concordance with existing 
translations, (2) conceptual equivalence across and (3) linguistic consistency within 
languages. METHODS: The translation process was conducted as follows: forward 
translations on the basis of translations of version 5 produced by psychiatrists appointed 
by the authors, backward translation, clinician review and whenever possible, review 
by the psychiatrists who had coordinated the initial translations. The authors contrib-
uted to the process by identifying the original concepts and reviewing the backward 
